Tetra Bio Pharma Inc. | Balance Sheet

Fiscal year is December-November. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
159.30
300.00
20.10
1,218.60
2,193.10
13,585.70
Total Accounts Receivable
2.80
22.10
5.10
62.70
194.20
759.40
Inventories
-
-
-
-
44.50
-
Other Current Assets
3.80
18.80
0.80
90.90
61.00
182.40
Total Current Assets
165.80
340.80
26.10
1,372.20
2,492.80
14,527.50
Intangible Assets
-
-
-
-
8,645.90
8,638.70
Other Assets
-
-
13.90
216.00
-
264.70
Total Assets
165.80
340.80
40.00
1,588.20
11,138.70
23,430.80
Accounts Payable
6.00
-
-
-
490.40
Other Current Liabilities
1.30
118.30
270.20
191.70
8.60
Total Current Liabilities
7.40
118.30
270.20
191.70
499.10
Total Liabilities
7.40
118.30
270.20
191.70
499.10
Common Equity (Total)
158.50
222.50
230.20
1,449.30
11,162.40
Total Shareholders' Equity
158.50
222.50
230.20
1,449.30
11,162.40
Total Equity
158.50
222.50
230.20
1,396.50
10,639.60
Liabilities & Shareholders' Equity
165.80
340.80
40.00
1,588.20
11,138.70
Accumulated Minority Interest
-
-
-
52.70
522.80

About Tetra Bio Pharma

View Profile
Address
365 rue St-Jean
Longueuil Québec J4H 2X7
Canada
Employees -
Website http://www.tetrabiopharma.com
Updated 07/08/2019
Tetra Bio-Pharma, Inc. engages in the development of cannabis-derived pharmaceuticals. It also distributes natural health products and cosmetics. It develops medication to alleviate symptoms related to pain, insomnia and anxiety disorders in patients suffering from cancer and other chronic and terminal diseases.